Publications of Mira Dalal
All genres
Journal Article (17)
2014
Journal Article
152 (1), pp. 255 - 260 (2014)
Olanzapine and clozapine differently affect sleep in patients with schizophrenia: Results from a double-blind, polysomnographic study and review of the literature. SCHIZOPHRENIA RESEARCH 2012
Journal Article
135 (1-3), pp. 123 - 127 (2012)
Sleep propensity at daytime as assessed by Multiple Sleep Latency Tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine. Schizophrenia Research
Journal Article
35 (2), pp. 231 - 236 (2012)
Glucose Tolerance in Patients with Narcolepsy. Sleep 2009
Journal Article
34 (1), pp. 118 - 128 (2009)
Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Psychoneuroendocrinology 2008
Journal Article
17 (Suppl. 1), p. 201 - 201 (2008)
What does paroxetine do with sleep? Its effects in mdr 1a/1b (-/-) and fvb wild-type mice. Journal of Sleep Research 2007
Journal Article
27 (6), pp. 662 - 666 (2007)
Clozapine and olanzapine are associated with food craving and binge eating - Results from a randomized double-blind study. Journal of Clinical Psychopharmacology
Journal Article
40 (5), p. 241 - 241 (2007)
Daytime sleep after glucose intake in patients with narcolepsy. Pharmacopsychiatry
Journal Article
34 (2), pp. 93 - 94 (2007)
Gabapentin bei einer Patientin mit Panikstörung und Unverträglichkeit von Carbamazepin während des Benzodiazepinentzugs. Psychiatrische Praxis
Journal Article
2, pp. 293 - 302 (2007)
Immunoendocrine abnormalities in narcolepsy. Sleep Medicine Clinics 2006
Journal Article
114, pp. 322 - 328 (2006)
Low doses of dexamethasone affect immune parameters in the absence of immunological stimulation. Experimental and Clinical Endocrinology & Diabetes 2005
Journal Article
38 (5), p. 230 - 230 (2005)
Impaired glucose tolerance in patients with narcolepsy. Pharmacopsychiatry 2004
Journal Article
286 (6), pp. E963 - E967 (2004)
Sleep enhances nocturnal plasma ghrelin levels in healthy subjects. American Journal of Physiology-Endocrinology and Metabolism 2003
Journal Article
36 (5), p. 218 - 218 (2003)
Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects. Pharmacopsychiatry
Journal Article
36 (5), pp. 263 - 264 (2003)
Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects - First results from a double-blind, placebocontrolled study. Pharmacopsychiatry
Journal Article
8, pp. 836 - 837 (2003)
Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects. Molecular Psychiatry 2002
Journal Article
11 (3), p. 273 - 273 (2002)
Undetectable CSF level of orexin A (hypocretin-1) in a HLA-DR2 negative patient with narcolepsy-cataplexy. Journal of Sleep Research 2001
Journal Article
56, pp. 1749 - 1751 (2001)
Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology Book Chapter (1)
2001
Book Chapter
Leptin and psychopharmacology. In: Psychoneuroimmunology. Hypotheses and Current Research. Advances in Biological Psychiatry, Vol. 20, pp. 20 - 29 (Eds. Sperner-Unterweger, B.; Fleischhacker, W.; Kaschka, W.). Karger, Basel (2001)